Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Richeldi

Showing results (41-50 of 356) with videos related to

Pageof 36
Sort By:
The European Respiratory Journal|July 27, 2019
Demystifying fibrotic hypersensitivity pneumonitis diagnosis: it's all about shades of greySimon L F Walsh, Luca Richeldi
The Lancet. Infectious Diseases|May 28, 2005
Interferon gamma assays for tuberculosisAjit Lalvani, Luca Richeldi, Heinke Kunst
The American Journal of Medicine|December 25, 2012
The replyPaolo Spagnolo, Fabrizio Luppi, Luca Richeldi
Thorax|April 13, 2016
Study the past to divine the future. Confucius' wisdom doesn't work for idiopathic pulmonary fibrosisMartin Kolb, Gisli Jenkins, Luca Richeldi
Current Opinion in Pulmonary Medicine|July 15, 2022
Novel insights in fibrotic pulmonary sarcoidosisAlessia Comes, Carmelo Sofia, Luca Richeldi
American Journal of Respiratory and Critical Care Medicine|January 31, 2019
Subclinical Interstitial Lung Abnormalities: Lumping and Splitting RevisitedSimon L F Walsh, Luca Richeldi
Nature Reviews. Drug Discovery|August 13, 2011
PirfenidoneLuca Richeldi, Uma Yasothan, Peter Kirkpatrick
Respirology (Carlton, Vic.)|November 24, 2015
Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural historyGiacomo Sgalla, Alice Biffi, Luca Richeldi
European Journal of Internal Medicine|August 27, 2020
Early diagnosis of idiopathic pulmonary fibrosis: Closer to the goal?Alessia Comes, Giacomo Sgalla, Luca Richeldi
Expert Opinion on Biological Therapy|October 5, 2023
An up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosisJacopo Simonetti, Giacomo Sgalla, Luca Richeldi
Pageof 36

Showing results (41-50 of 356) with videos related to

Sort By:
Pageof 36
The European Respiratory Journal|July 27, 2019
Demystifying fibrotic hypersensitivity pneumonitis diagnosis: it's all about shades of greySimon L F Walsh, Luca Richeldi
The Lancet. Infectious Diseases|May 28, 2005
Interferon gamma assays for tuberculosisAjit Lalvani, Luca Richeldi, Heinke Kunst
The American Journal of Medicine|December 25, 2012
The replyPaolo Spagnolo, Fabrizio Luppi, Luca Richeldi
Thorax|April 13, 2016
Study the past to divine the future. Confucius' wisdom doesn't work for idiopathic pulmonary fibrosisMartin Kolb, Gisli Jenkins, Luca Richeldi
Current Opinion in Pulmonary Medicine|July 15, 2022
Novel insights in fibrotic pulmonary sarcoidosisAlessia Comes, Carmelo Sofia, Luca Richeldi
American Journal of Respiratory and Critical Care Medicine|January 31, 2019
Subclinical Interstitial Lung Abnormalities: Lumping and Splitting RevisitedSimon L F Walsh, Luca Richeldi
Nature Reviews. Drug Discovery|August 13, 2011
PirfenidoneLuca Richeldi, Uma Yasothan, Peter Kirkpatrick
Respirology (Carlton, Vic.)|November 24, 2015
Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural historyGiacomo Sgalla, Alice Biffi, Luca Richeldi
European Journal of Internal Medicine|August 27, 2020
Early diagnosis of idiopathic pulmonary fibrosis: Closer to the goal?Alessia Comes, Giacomo Sgalla, Luca Richeldi
Expert Opinion on Biological Therapy|October 5, 2023
An up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosisJacopo Simonetti, Giacomo Sgalla, Luca Richeldi
Pageof 36